@erictopol I had to read the substack several times as it confuses rates and excess. I know you're exceptionally busy, so hoping to help you update easily so it agrees clearly with the table: "The results are summarized below. By rapid antigen testing, viral rebound occurred in 14% of the Paxlovid group and in 9% of controls, for an excess of 5%. With respect to symptoms, the rate was nearly 18% compared with 7%, giving an excess of 12% for Paxlovid versus controls."